| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3855073 | Journal of Renal Nutrition | 2015 | 5 Pages |
Abstract
In this pilot study, AA therapy appeared safe and effective at reducing C-Alb levels in hemodialysis patients compared with no treatment. The impact of reduced protein carbamylation on clinical outcomes should be further investigated.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sahir MD, MMSc, Guillermo MD, Caitlin A. BA, Joseph J. BA, S. Ananth MD, Ravi I. MD, MPH, Anders H. MD, PhD,